COVID-19

New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target. The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality.

Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) can trace its origins to the Ecole de Medicine de Pondicherry established by the French Government in 1823. In 1956 foundation for new medical college was laid and in 1964, hospital was inaugurated. JIPMER became an institution of national importance under the Ministry of Health and Family Welfare, Government of India in the year 2008. It is an institution established for teaching, research and patient care in the area of health. JIPMER spreads over 192 acres.

The COVID-19 Vaccine Janssen has been given regulatory approval by the Medicines and Healthcare products Regulatory Agency . This is the fourth COVID-19 vaccine to be authorised by the UKs independent regulator and is the first to be approved for protection against COVID-19 with a single dose.

Moderna, Inc a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents has met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination. In the study, no cases of COVID-19 were observed in participants who had received two doses of the Moderna COVID-19 vaccine using the primary definition.

Roche India and Cipla Limited announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit 200,000 patients as each of the 100,000 packs that will be available in India offers treatment for two patients. Cipla will distribute the product by leveraging its strong distribution strengths across the country. The drug will be available through leading hospitals and COVID treatment centers.

Moderna, Inc a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan granted special approval under article 14-3 of the Pharmaceuticals and Medical Devices Act for emergency use of Moderna’s mRNA COVID-19 vaccine, now known as COVID-19 Vaccine Moderna Intramuscular Injection, in Japan. Distribution by Takeda in Japan will begin immediately.

Mylab Discovery Solutions announced the first self use Rapid test of India, Coviself which is approved by ICMR. Each Coviself test kit will be provided with all testing materials, instructions to use leaflet and a biohazard bag to safely dispose of after testing. It is available at economical pricing of Rs 250. Last year, Mylab launched the first RTPCR test of India for COVID-19.

School of Tropical Medicine is one of the seven such Institutions dedicated to research, care and cure of tropical diseases. STM was founded by Sir Leonard Rogers way back in 1914. The corridors of STM had regular footfall of eminent researchers like Leonard Rogers, Ronald Ross, R Knowels, UN Brahmachari, JB Chatterjee, RN Chopra and many others. The foundation stone of the School of Tropical Medicine was laid by the Governor. Lord Carmichael in the year 1914 on 24th February at the initiative of Sir Leonard Rogers.

School of Tropical Medicine is one of the seven such Institutions dedicated to research, care and cure of tropical diseases. STM was founded by Sir Leonard Rogers way back in 1914. The corridors of STM had regular footfall of eminent researchers like Leonard Rogers, Ronald Ross, R Knowels, UN Brahmachari, JB Chatterjee, RN Chopra and many others. The foundation stone of the School of Tropical Medicine was laid by the Governor. Lord Carmichael in the year 1914 on 24th February at the initiative of Sir Leonard Rogers.